Skip header and navigation

Narrow By

37 records – page 1 of 2.

Methotrexate (MTX) therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams34942
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
1138
Available Online
View Pamphlet
Methotrexate (MTX) may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about what MTX is, combination therapy in IBD, who should not take MTX, how MTX is given, and possible side effects, and what you can do to lower the chance of side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Alternate Title
Methotrexate (MTX) therapy for IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (13 p.) : digital, PDF file
Subjects (MeSH)
Methotrexate
Inflammatory Bowel Diseases
Immunosuppressive Agents
Subjects (LCSH)
Methotrexate
Immunosuppressive agents
Inflammatory bowel diseases
Specialty
Medications
Abstract
Methotrexate (MTX) may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about what MTX is, combination therapy in IBD, who should not take MTX, how MTX is given, and possible side effects, and what you can do to lower the chance of side effects.
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1138
Less detail

Treatment of high potassium with Kayexalate powder in hemodialysis

https://libcat.nshealth.ca/en/permalink/chpams35337
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
1445
Available Online
View Pamphlet
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Renal Dialysis
Polystyrene sulfonic acid
Hyperkalemia
Subjects (LCSH)
Drugs
Low-potassium diet
Specialty
Nephrology
Medications
Abstract
Kayexalate® is a medication that treats high potassium levels in the body. High potassium levels can be dangerous if you have kidney disease. This pamphlet explains why you may need this medication, how to take it, side effects, and how to store it.
Notes
Previous title: Treatment of high potassium with Kayexalate powder in hemodialysis patients
Responsibility
Prepared by: Renal Program
Pamphlet Number
1445
Less detail

Corticosteroid therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35480
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
1546
Available Online
View Pamphlet
A corticosteroid medication may help you manage your inflammatory bowel disease (IBD). This pamphlet explains what corticosteroids are, how well they work, and how they are given. Information about precautions, possible side effects, and what to expect after your treatment is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Alternate Title
Corticosteroid therapy for IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Prednisone
Subjects (LCSH)
Inflammatory bowel diseases
Prednisone
Specialty
Medications
Abstract
A corticosteroid medication may help you manage your inflammatory bowel disease (IBD). This pamphlet explains what corticosteroids are, how well they work, and how they are given. Information about precautions, possible side effects, and what to expect after your treatment is included.
Notes
This pamphlet replaced pamphlet 1139: Prednisone Therapy
Previous title: Corticosteroid therapy in inflammatory bowel disease (IBD)
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1546
Less detail

Azathioprine or mercaptopurine therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35565
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
1079
Available Online
View Pamphlet
Azathioprine (Imuran®) or mercaptopurine may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about combination therapy in IBD, possible side effects of these medications, and what you can do to lower the chance of side effects.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Alternate Title
Azathioprine or mercaptopurine therapy for IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.): digital, PDF file
Subjects (MeSH)
Immunosuppressive Agents
Azathioprine
Mercaptopurine
Subjects (LCSH)
Immunosuppressive agents
Specialty
Medications
Abstract
Azathioprine (Imuran®) or mercaptopurine may help you manage your over-active immune response caused by your inflammatory bowel disease (IBD). This pamphlet gives information about combination therapy in IBD, possible side effects of these medications, and what you can do to lower the chance of side effects.
Notes
Previous title: Azathioprine (Imuran) therapy
Previous title: Azathioprine and mercaptopurine therapy
Responsibility
Prepared by: Nova Scotia Collaborative Inflammatory Bowel Disease Program
Pamphlet Number
1079
Less detail
Nova Scotia Health Authority. CVAD Practice Committee. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
1571
Available Online
View Pamphlet
A PICC (peripherally inserted central catheter) line is a long intravenous (I.V.) catheter (tube). It is put into a vein in your arm and threaded into a vein above your heart. This pamphlet explains how it will be inserted, risks, taking care of your line, and symptoms to watch for.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. CVAD Practice Committee
Alternate Title
Peripherally inserted central catheter line
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (10 p.) : digital, PDF file
Subjects (MeSH)
Catheterization, Peripheral
Medications
Subjects (LCSH)
Catheterization
Drugs
Specialty
Medications
Abstract
A PICC (peripherally inserted central catheter) line is a long intravenous (I.V.) catheter (tube). It is put into a vein in your arm and threaded into a vein above your heart. This pamphlet explains how it will be inserted, risks, taking care of your line, and symptoms to watch for.
Responsibility
Prepared by: CVAD Practice Committee
Pamphlet Number
1571
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0294
Available Online
View Pamphlet
Beta blockers are medications used to treat high blood pressure and angina (chest pain), and to lower the risk of repeated heart attacks. This pamphlet explains how to take and store these medications. Possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Adrenergic Agents
Subjects (LCSH)
Adrenergic beta blockers
Specialty
Medications
Abstract
Beta blockers are medications used to treat high blood pressure and angina (chest pain), and to lower the risk of repeated heart attacks. This pamphlet explains how to take and store these medications. Possible side effects are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0294
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0613
Available Online
View Pamphlet
Angiotensin converting enzyme (ACE) inhibitors are medications that can be used to treat high blood pressure and certain heart conditions (like heart attacks, heart failure), and kidney disease. This pamphlet explains how to take and store these medications. Possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Angiotensin-Converting Enzyme Inhibitors
Subjects (LCSH)
Angiotensin converting enzyme--Inhibitors
Specialty
Medications
Abstract
Angiotensin converting enzyme (ACE) inhibitors are medications that can be used to treat high blood pressure and certain heart conditions (like heart attacks, heart failure), and kidney disease. This pamphlet explains how to take and store these medications. Possible side effects are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0613
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2024.
Pamphlet Number
0075
Available Online
View Pamphlet
Statins are medications used to help lower high cholesterol levels. This pamphlet explains how to take and store this medication. Possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2024
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Subjects (LCSH)
Statins (Cardiovascular agents)
Specialty
Medications
Abstract
Statins are medications used to help lower high cholesterol levels. This pamphlet explains how to take and store this medication. Possible side effects are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0075
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0071
Available Online
View Pamphlet
The pamphlet explains what Aspirin® is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are also listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (5 p.) : digital, PDF file
Subjects (MeSH)
Aspirin
Subjects (LCSH)
Aspirin
Specialty
Medications
Abstract
The pamphlet explains what Aspirin® is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are also listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0071
Less detail
Nova Scotia Health Authority. QEII. Pharmacy Department. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
0249
Available Online
View Pamphlet
This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Pharmacy Department
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (4 p.) : digital, PDF file
Subjects (MeSH)
Anticoagulants
Subjects (LCSH)
Anticoagulants (Medicine)
Specialty
Medications
Abstract
This pamphlet explains what clopidogrel is used for and how to take it. Other topics covered in the pamphlet are: who should not take this medication, how to store this medication, what to do if you miss a dose, and medications and foods to avoid. Symptoms that would need to be checked in the Emergency Department are listed.
Responsibility
Prepared by: Pharmacy Department
Pamphlet Number
0249
Less detail

Taking your medications when you are sick after a kidney transplant

https://libcat.nshealth.ca/en/permalink/chpams35858
Nova Scotia Health Authority. QEII. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1805
Available Online
View Pamphlet
This pamphlet lists medications you should not take if you get very sick with diarrhea (loose, watery poop), or you are vomiting (throwing up). These medications keep your blood pressure down, and protect your kidneys and heart. They can also harm you if you do not have enough fluids in your body. Diarrhea and vomiting can make you dehydrated (not have enough fluids in your body). Information about what to do if you have not taken your medication(s) for more than 1 day (24 hours) and/or cannot …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QEII. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Kidney transplantation
Medications
Subjects (LCSH)
Kidneys--Transplantation
Drugs
Specialty
Nephrology
Medications
Abstract
This pamphlet lists medications you should not take if you get very sick with diarrhea (loose, watery poop), or you are vomiting (throwing up). These medications keep your blood pressure down, and protect your kidneys and heart. They can also harm you if you do not have enough fluids in your body. Diarrhea and vomiting can make you dehydrated (not have enough fluids in your body). Information about what to do if you have not taken your medication(s) for more than 1 day (24 hours) and/or cannot keep fluids down without vomiting is included.
Notes
Previous title: Taking your medications when you are ill after a kidney transplant : a guide for patients with a kidney transplant
Responsibility
Prepared by: Kidney Transplant Clinic, QEII
Pamphlet Number
1805
Less detail
Nova Scotia Health Authority. QE II. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1937
Available Online
View Pamphlet
Lithium is a mood stabilizer. It is most often used in bipolar disorder to prevent or treat mania or depression. This pamphlet explains what symptoms lithium will help with, how your dose of lithium is chosen, possible side effects, and signs of lithium toxicity (too much lithium).
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QE II. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Lithium - therapeutic use
Bipolar Disorder - drug therapy
Mania - drug therapy
Depression, Bipolar - drug therapy
Subjects (LCSH)
Lithium--Therapeutic use
Manic-depressive illness
Specialty
Medications
Abstract
Lithium is a mood stabilizer. It is most often used in bipolar disorder to prevent or treat mania or depression. This pamphlet explains what symptoms lithium will help with, how your dose of lithium is chosen, possible side effects, and signs of lithium toxicity (too much lithium).
Responsibility
Prepared by: Pharmacy Services, QE II
Pamphlet Number
1937
Less detail

Paliperidone (Invega®) and paliperidone palmitate (Invega Sustenna®, Invega Trinza®

https://libcat.nshealth.ca/en/permalink/chpams36494
Nova Scotia Health Authority. QE II. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
1938
Available Online
View Pamphlet
Paliperidone is most often used to treat psychosis or mania. This pamphlet explains how to take paliperidone, what symptoms it will help with, and possible side effects. Rare, serious side effects that require a visit to the Emergency Department are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. QE II. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (6 p.) : digital, PDF file
Subjects (MeSH)
Paliperidone Palmitate - therapeutic use
Psychotic Disorders - drug therapy
Mania - drug therapy
Subjects (LCSH)
Psychoses--Treatment
Mania
Specialty
Medications
Abstract
Paliperidone is most often used to treat psychosis or mania. This pamphlet explains how to take paliperidone, what symptoms it will help with, and possible side effects. Rare, serious side effects that require a visit to the Emergency Department are listed.
Notes
Previous title: Paliperidone (Invega); Paliperidone Palmitate (Invega Sustenna)
Responsibility
Prepared by: Pharmacy Services, QE II
Pamphlet Number
1938
Less detail

Risankizumab (Skyrizi®) therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams38191
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2345
Available Online
View Pamphlet
Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative Inflammatory Bowel Disease Program
Alternate Title
Risankizumab (Skyrizi®) therapy for IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document (9 p.) : digital, PDF file
Subjects (MeSH)
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Gastrointestinal System
Medications
Abstract
Risankizumab is a biologic medication. A biologic medication is a type of medication that treats inflammation. This pamphlet explains how risankizumab works, how it is given, and how long you can expect to take it. Precautions, side effects, and what to expect after treatment are explained. Side effects that require contacting your primary health care provider are listed.
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
2345
Less detail

Using medications safely when you have kidney disease

https://libcat.nshealth.ca/en/permalink/chpams38205
Nova Scotia Health Authority. Renal Program. Halifax, NS: Nova Scotia Health Authority , 2023.
Pamphlet Number
2357
Available Online
View Pamphlet
People with kidney disease often take many medications. These medications can help with your kidney disease and other medical conditions (like high blood pressure [hypertension] or diabetes). It is important to take your medications regularly and as told by your health care provider. This pamphlet explains what you need to know about your medications and non-prescription medications, how you can make sure your medications are OK for your level of kidney function, and what will happen if a medic…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Renal Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2023
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Medications
Kidney Diseases - drug therapy
Subjects (LCSH)
Drugs
Kidney disease
Specialty
Medications
Nephrology
Abstract
People with kidney disease often take many medications. These medications can help with your kidney disease and other medical conditions (like high blood pressure [hypertension] or diabetes). It is important to take your medications regularly and as told by your health care provider. This pamphlet explains what you need to know about your medications and non-prescription medications, how you can make sure your medications are OK for your level of kidney function, and what will happen if a medication is not safe for your level of kidney function. Information about what to do if you have questions is included.
Responsibility
Prepared by: Renal Program
Pamphlet Number
2357
Less detail

Adalimumab therapy for inflammatory bowel disease (IBD)

https://libcat.nshealth.ca/en/permalink/chpams35127
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1207
Available Online
View Pamphlet
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Alternate Title
Adalimumab therapy for IBD
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Adalimumab
Inflammatory Bowel Diseases - drug therapy
Subjects (LCSH)
Inflammatory bowel diseases
Specialty
Medications
Abstract
Your health care provider feels that treatment with adalimumab may help you manage your inflammatory bowel disease (IBD). This pamphlet describes what adalimumab is and some important aspects of therapy with this medication. Precautions and possible side effects are listed.
Notes
Previous title: Adalimumab (Humira) therapy
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1207
Less detail

Polyoma virus and BK virus

https://libcat.nshealth.ca/en/permalink/chpams35425
Nova Scotia Health Authority. Kidney Transplant Clinic. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1510
Available Online
View Pamphlet
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of …
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Kidney Transplant Clinic
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([4] p.) : digital, PDF file
Subjects (MeSH)
Polyomavirus
BK Virus
Kidney Transplantation - adverse effects
Immunosuppressive Agents - adverse effects
Subjects (LCSH)
Polyomaviruses
Kidneys--Transplantation
Immunosuppressive agents
Specialty
Nephrology
Medications
Abstract
BK virus is a part of the polyoma virus family. About 80% of people carry the virus. People usually get this virus as children. It can stay inactive in your body without causing harm for many years. It can become active if you are immunocompromised (your immune system is weak). People who have had a kidney transplant and are taking immunosuppressive medications (medications that suppress [lower] your immune system) are at risk of infection from the virus. This pamphlet explains the symptoms of BK virus, how BK virus is diagnosed, and how it is treated.
Responsibility
Prepared by: Kidney Transplant Clinic
Pamphlet Number
1510
Less detail

Vedolizumab (Entyvio) therapy

https://libcat.nshealth.ca/en/permalink/chpams35620
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1623
Available Online
View Pamphlet
Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when und…
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Nova Scotia Collaborative IBD Program
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document (11 p.) : digital, PDF file
Subjects (MeSH)
Gastrointestinal Agents
Colitis, Ulcerative - drug therapy
Crohn Disease - drug therapy
Subjects (LCSH)
Gastrointestinal agents
Ulcerative colitis
Crohn's disease
Specialty
Medications
Abstract
Vedolizumab (Entyvio®) is given to manage inflammatory bowel disease (IBD), ulcerative colitis, or Crohn's disease. This pamphlet gives you information about vedolizumab to help you make an informed decision about whether or not to use it. Topics include: a brief description of the medicine, who can take it, how it works, how it is given, how long you will need to take it, cost, precautions, and side effects. A list of symptoms to watch out for is listed. Other important things to know when undergoing this treatment are provided.
Responsibility
Prepared by: Nova Scotia Collaborative IBD Program
Pamphlet Number
1623
Less detail

Aripiprazole (Abilify, Abilify Maintena)

https://libcat.nshealth.ca/en/permalink/chpams35626
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1627
Available Online
View Pamphlet
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Aripiprazole
Subjects (LCSH)
Antipsychotic drugs
Specialty
Medications
Abstract
Aripiprazole is most often used to treat psychosis. It is also used to treat mania and sometimes depression. This pamphlet explains how to take aripiprazole, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1627
Less detail

Risperidone (Risperdal, Risperdal Consta)

https://libcat.nshealth.ca/en/permalink/chpams35648
Nova Scotia Health Authority. Pharmacy Services. Halifax, NS: Nova Scotia Health Authority , 2022.
Pamphlet Number
1639
Available Online
View Pamphlet
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Available Online
View Pamphlet
Corporate Author
Nova Scotia Health Authority. Pharmacy Services
Place of Publication
Halifax, NS
Publisher
Nova Scotia Health Authority
Date of Publication
2022
Format
Pamphlet
Language
English
Physical Description
1 electronic document ([2] p.) : digital, PDF file
Subjects (MeSH)
Risperidone
Subjects (LCSH)
Antipsychotic drugs
Specialty
Medications
Abstract
Risperidone is most often used to treat psychosis or mania. It is also used to treat some symptoms of dementia. This pamphlet explains how to take risperidone, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
Responsibility
Prepared by: Pharmacy Services
Pamphlet Number
1639
Less detail

37 records – page 1 of 2.